A Review on Bioactivities of Honey Bee Venom

The Honeybee (Apis mellifera) is one of the world’s most beneficial insects, as it plays a critical role in many terrestrial ecosystems. The use of honeybee products has been documented for thousands of years in many cultures for the treatment of human diseases, and their healing properties have been documented in many religious texts. The present study sets out to compile information on the history, chemical composition and scientific evidence concerning bee venom research. The promising bioactivities have the potential to provide practical directions for further investigation. PubMed database, Google Scholar Library, research articles, books, and relevant web pages have been accessed to accumulate data so that the updated information included in this study is as current as possible. At least 18 pharmacologically active components including various enzymes, peptides, and amines are present in bee venom. Medicinal use of bee venom therapy wields significant in vivo and in vitro outcomes to some extent mitigate the effects of Parkinson’s disease, Alzheimer’s disease, HIV, arthritis, liver fibrosis, cancer, tumors, fibrotic diseases, Lyme disease, etc. The effects of bee venom were the first documented in 1888 with the publication of a European clinical study conducted on its impact on rheumatism. According to a study published in the journal, bee venom has been used to treat various conditions for centuries. Such research activities confirm the therapeutic effectiveness of bee venom and as a potential future biomedicine.

Potencial antiviral e virucida da melitina e apamina contra herpesvírus bovino tipo 1 e vírus da diarreia viral bovina / Antiviral and virucidal potential of melittin and apamin against bovine herpesvirus type 1 and bovine viral diarrhea virus

A busca por alternativa aos fármacos sintéticos têm revelado descobertas no campo da farmacologia e, nesse sentido, melitina e apamina, dois constituintes do veneno de abelhas, foram descritas com várias ações farmacológicas. Este estudo objetivou avaliar in vitro as capacidades antiviral e virucida destes componentes. Para tanto, células MDBK (Madin Darby Bovine Kidney), após verificação das respectivas doses tóxicas por ensaio MTT ((3-(4,5 dimetiltiazol-2yl)-2-5-difenil-2H tetrazolato de bromo), foram cultivadas em microplacas e tratadas com diferentes concentrações de apamina, melitina e sua associação. Esse tratamento ocorreu antes e após a infecção com 0,1 MOI (multiplicidade de infecção) de cepas citopatogênicas de herpesvírus bovino tipo 1 (BoHV-1) cepa Los Angeles e vírus da diarreia viral bovina (BVDV) cepa NADL. Após incubação por 72 horas, 37oC, as células foram submetidas ao ensaio MTT para estimativa da viabilidade celular. Em experimento paralelo, placas que foram submetidas ao mesmo procedimento sofreram ciclo de congelamento e descongelamento das células, para rompimento das mesmas e mensuração dos títulos virais. O ensaio virucida foi realizado incubando-se suspensões de BoHV-1 e BVDV com as soluções de apamina, melitina e associação por 24 horas a 37oC e 22oC. O título viral foi avaliado às 0 horas, 1, 2, 4, 8 e 24 horas de incubação. A concentração citotóxica para 50% das células (CC50) de melitina foi 2,32 μg/ml e apamina não demonstrou toxicidade à maior concentração testada (100μg/ml). Houve efeito antiviral da melitina sobre BoHV-1, especialmente na concentração de 2μg/ml, onde observou-se 85,96% de viabilidade celular quando o tratamento foi realizado antes da infecção e 86,78% de viabilidade quando o tratamento foi realizado após a infecção. Houve ainda redução de 90% das partículas virais de BoHV-1. Em menores concentrações (1 e 1,5μg/ml) de melitina não houve atividade antiviral, pois a viabilidade celular foi baixa, demonstrando efeito citopático do vírus. Na associação das duas substâncias houve queda no título de BVDV e observou-se maior viabilidade celular quando comparados à ação isolada dos composto sobre este vírus. Isso se confirma na atividade virucida, uma vez que houve decréscimo de 90% das partículas virais de BVDV com a associação dos dois compostos do veneno de abelhas. Atuando individualmente, melitina apresentou efeito antiviral e virucida frente ao BoHV-1, zerando seu título em apenas 2 horas a 37oC. Conclui-se que melitina tem ação antiviral e virucida frente ao BoHV-1 e sua associação com apamina potencializou seus efeitos frente ao BVDV.(AU)

The search for an alternative to synthetic drugs have revealed discoveries in the field of pharmacology and, according to melittin and apamin, two components of bee venom which have been described were with various pharmacological actions.This study aimed to evaluate the in vitro antiviral and virucidal capabilities of these components. Therefore, after verification of their toxic doses by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, MDBK cells (Madin Darby Bovine Kidney) have been cultivated in microplates and treated with different concentrations of apamin, melittin and its association. This treatment occurred before and after infection with MOI (multiplicity of infection) 0.1 of cytopathogenic strains of bovine herpesvirus type 1 (BoHV-1) strain Los Angeles and bovine viral diarrhea virus (BVDV) strain NADL. After incubation for 72 hours, 37°C, the cells were submitted to MTT assay to estimate cell viability. In parallel experiments, plates were subjected to the same procedure suffered freezing and thawing cycle the cells to rupture the same and measurement of viral titers. The virucidal assay was performed by incubating suspension of bovine herpesvirus type-1 and BVDV with apamin solutions, melittin and association for 24 hours at 37°C and 22°C. The viral titer was evaluated at 0 hours, 1, 2, 4, 8 and 24 hours of incubation. The cytotoxic concentration to 50% of the cells (CC50) of melittin was 2.32g/mL and apamin did not show toxicity at the greater concentration tested (100μg/mL). There was antiviral effect of melittin on bovine herpesvirus type-1, especially at a concentration of 2μg/mL, where was observed 85.96% cell viability when treatment was performed before the infection and 86.78% viability when the treatment was carried out after infection. There was also a 90% reduction of viral particles of bovine herpesvirus type-1. In lower concentrations (1 and 1.5μg/mL) melittin no antiviral activity because cell viability was low, showing cytopathic effect of the virus. At the association two substances there were a decrease in the title of BVDV and there was higher cell viability when compared to the isolated action of the compounds of this virus. This is confirmed in the virucidal activity, since there was a decrease of 90% of the viral particles of BVDV with the combination of the two compounds of bee venom. Acting individually, melittin showed antiviral effect and virucidal against for BoHV-1, zeroing its title in just 2 hours at 37°C. It is concluded that melittin has antiviral and virucidal action against the BoHV-1 and its association with apamin potentiate its effects against BVDV.(AU)

Antifungal Effects of Bee Venom Components on Trichophyton rubrum: A Novel Approach of Bee Venom Study for Possible Emerging Antifungal Agent

BACKGROUND: Bee venom (BV) has been widely investigated for potential medical uses. Recent inadvertent uses of BV based products have shown to mitigate signs of fungal infections. However, the component mediating the antifungal effect has not been identified. OBJECTIVE: This investigation compares bee venom in its whole and partial forms to evaluate the possible component responsible for the antifungal effect. METHODS: Forty-eight plates inoculated with Trichophyton rubrum were allocated into four groups. The groups were treated with raw BV (RBV), melittin, apamin and BV based mist (BBM) respectively and each group was further allocated accordingly to three different concentrations. The areas were measured every other day for 14 days to evaluate the kinetic changes of the colonies. RESULTS: The interactions of ratio differences over interval were confirmed in groups treated with RBV and BBM. In RBV, the level of differences were achieved in groups treated with 10 mg/100 µl (p=0.026) and 40 mg/100 µl (p=0.000). The mean difference of ratio in groups treated with RBV was evident in day 3 and day 5. The groups that were treated with melittin or apamin did not show any significant interaction. In BBM groups, the significant levels of ratio differences over time intervals were achieved in groups treated with 200 µl/100 µl (p=0.000) and 300 µl/100 µl (p=0.030). CONCLUSION: The the bee venom in its whole form delivered a significant level of inhibition and we concluded that the venom in separated forms are not effective. Moreover, BV based products may exert as potential antifungal therapeutics.

Revisión de tema: Aspectos toxinológicos y biomédicos del veneno de las abejas Apis mellifera / Toxicological and biomedical aspects of bee venom Apis mellifera

El veneno de abejas incluye compuestos orgánicos de bajo y alto peso molecular. Se encuentran en él péptidos simples como la apamina, polipéptidos como la melitina y enzimas como la fosfolipasa A2 y la hialuronidasa; recientemente se demostró que algunos citratos son también componentes mayores del veneno. La melitina y la fosfolipasa A2 son los componentes principales y más abundantes, cerca del 75 por ciento, en una relación 3:1. La melitina se adhiere a las membranas de los glóbulos rojos, produciendo hemólisis; la fosfolipasa A2, el mayor de los alergenos del veneno, actúa como agente bloqueador que puede provocar parálisis respiratoria. La apamina representa cerca del 2 por ciento del veneno total; es menos tóxica que los compuestos anteriores y se comporta como neurotoxina de acción motora; además de desencadenar un efecto cardioestimulante parecido al de las drogas adrenérgicas, tiene propiedades antiarrítmicas. Un 2 por ciento del veneno lo constituye el péptido MCD (Mast Cell Degranulation) o factor degranulador de los mastocitos, uno de los compuestos responsables de la liberación de histamina y serotonina. Adicionalmente, se han identificado compuestos como fosfatasa ácida, norepinefrina, dopamina e histamina. En esta revisión se exponen aspectos relacionados con la conformación y función del aparato picador, con la composición y acción del veneno, con el comportamiento y los hábitos de las abejas y, finalmente, con las medidas de manejo y tratamiento de sus picaduras; se procuró hacer una mirada comparativa de esos aspectos aplicados a las abejas europeas y a las africanizadas

Bee venom includes organic components of low and high molecular weight such as simple peptides like apamin, polypeptides like mellitin and enzymes like phospholipase A2 and hyaluronidase. It was recently demonstrated that some citrates are also important components of this venom. Mellitin and phospholipase A2 are the main and more abundant components, around 75%, in a ratio of 3:1; mellitin interacts with human red blood cells membranes producing hemolysis; and phospholipase A2, the main allergen of the venom, may act as blocking agent causing respiratory paralysis. Apamin represents about 2% of the total venom; it is less toxic than the aforementioned substances and acts as a motor neurotoxin; it is also responsible for triggering a cardiostimulant effect similar to that of adrenergic drugs; it has antiarrhythmic properties as well. Peptide MCD (Mast Cell Degranulation factor) constitutes 2% of the venom, and it is one of the components responsible for histamine and serotonin release. Additionally, other components have been identified such as acid phosphatase, norepinephrine, dopamine and histamine. This review discusses aspects of the conformation and function of the bee stinging apparatus, of venom composition and action and ofs the behavior and habits of these insects. Finally, handling and treatment of bees bites are discussed. Applied aspects of the European and Africanized bees are compared

Blockade of intrinsic oscillatory activity of cerebellar Purkinje cells by apamin and nickel

Intracellular recordings of oscillatory firing (bursting activity) were obtained from Purkinje cells (PCs) in rat cerebellar slices. Apamin inhibited post-burst hyperpolarizations (PBHs) progressively and finally terminated oscillatory firing activity of PCs. Apamin did not affect the amplitude or duration of the after-hyperpolarization (AHP) between spikes within the burst. In the voltage clamp mode, apamin shifted the whole-cell, quasi-steady state I/V relationship in an inward direction and abolished the zero slope resistance (ZSR) region by blocking outward current. Nickel (Ni2+) terminated oscillatory activity and also abolished the ZSR region. However, Ni2+ did not have progressive blocking action on the post-burst hyperpolarization before it blocked oscillatory activity. Ni2+ blocked an inward current at potentials positive to approximately -65 mV, which was responsible for the ZSR region and outward current at more negative potentials. These data indicated that oscillatory activity of PCs is sustained by a balance between a slow Ni2+ -sensitive inward current and an apamin-sensitive outward current in the region of ZSR of the whole-cell I/V curve.